Form4insider filings, from the source

Insider · CIK 0001950232

Andrew Reardon

Files at: LGND. On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $4.4M · 3net −$4.4M
$10k$10k$100k$100k$1M$1M$10M$10MbuyssalesJun 30Jul 11Jul 22Aug 2Aug 13Aug 24Sep 4

Reported trades — common stock

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Sep 3, 2026 SForm 4 →Sep 8, 6:34 pm EDTLIGAND PHARMACEUTICALS INCLGND5,000$286.09$1,430,43436,514−12.0%10b5-1
Aug 3, 2026 SForm 4 →Aug 4, 6:42 pm EDTLIGAND PHARMACEUTICALS INCLGND5,000$288.99$1,444,95141,514−10.7%10b5-1
Aug 3, 2026 MForm 4 →Aug 4, 6:42 pm EDTLIGAND PHARMACEUTICALS INCLGND5,000$52.27$261,35046,514—10b5-1
Jul 1, 2026 SForm 4 →Jul 6, 5:11 pm EDTLIGAND PHARMACEUTICALS INCLGND5,000$313.28$1,566,37741,514−10.7%10b5-1
Jun 30, 2026 JMForm 4 →Jul 6, 5:11 pm EDTLIGAND PHARMACEUTICALS INCLGND5,132$55.06$282,56446,514—10b5-1 late

Reported trades — derivatives (options, RSUs, warrants)

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Aug 3, 2026 MForm 4 →Aug 4, 6:42 pm EDTLIGAND PHARMACEUTICALS INCLGND5,000——29,444—10b5-1
Jul 1, 2026 MForm 4 →Jul 6, 5:11 pm EDTLIGAND PHARMACEUTICALS INCLGND5,000——34,444—10b5-1